State Legislative Landscape in 2025 Despite a significant number of bills in 2023 and 2024 that would have required mandated coverage of GLP-1s in Medicaid, state employee health plans, or for health insurers regulated by the state, only Arkansas, California, Maryland, New Mexico, Pennsylvania, and Texas have introduced legislation mandating coverage in 2025 to date
Maintenance doses of Zepbound are 5 mg, 10 mg, and 15 mg per week
In the authors anecdotal experience, when further uptitration is not tolerated, but treatment effects are noted, maintaining the patient at the lower tolerated dose may be preferable to discontinuation
A critical consideration is that rapid weight loss from any causewhether through medication, surgery, or lifestyle modificationis associated with bone density reduction, making it challenging to isolate the independent effect of GLP-1 medications from the effect of weight loss itself
Buckley, S
If you get approved, the pharmacy ships your medication (cold-chain) directly to your door